The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer

Recently, an anti-angiogenic strategy to treat gastric cancer (GC) has been successful with the use of ramucirumab. The comprehensive network of VEGF, soluble VEGF receptor-2 (sVEGFR2) and cytokines and other angiogenic factors (CAF) in GC has not been reported. We aimed to reveal the CAF signature...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Am J Cancer Res
Autores principales: Ock, Chan-Young, Nam, Ah-Rong, Bang, Ju-Hee, Kim, Tae-Yong, Lee, Kyung-Hun, Han, Sae-Won, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Oh, Do-Youn
Formato: Artigo
Lenguaje:Inglês
Publicado: e-Century Publishing Corporation 2015
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4697684/
https://ncbi.nlm.nih.gov/pubmed/26807318
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares